Prelude Therapeutics Incorporated (PRLD)
NASDAQ
$4.06-3.33%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 277,767
- 52-week high
- —
- 52-week low
- —
- Open
- $4.24
- Day high
- $4.32
- Day low
- $3.95
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $12.14M | -$99.5M | -$1.29 |
| 2024 | $7M | -$127.17M | -$1.68 |
| 2023 | — | -$121.83M | -$2.02 |
| 2022 | — | -$115.44M | -$2.44 |
| 2021 | — | -$111.69M | -$2.43 |
About Prelude Therapeutics Incorporated
A company overview for Prelude Therapeutics Incorporated is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is Prelude Therapeutics Incorporated's stock price today?
- PRLD is trading at $4.06 as of Jul 20, 2026.
- Does Prelude Therapeutics Incorporated pay a dividend?
- Prelude Therapeutics Incorporated did not pay a dividend in its most recent reported fiscal year.